Stock Events

Stock Events

CytomX Therapeutics (6C1.F) Q3 2024 Earnings

8AugConfirmed

Q2 2023

Q3 2023

Q2 2024

Q3 2024

-0.09

-0.01

0.07

0.16

Details

Expected EPS

-0.09141413395999999

Actual EPS

-0.07328080000000001

Surprise EPS

0.02

Surprise Percent

+19.84%

Description

CytomX Therapeutics (6C1.F) has reported earnings of -0.07328080000000001 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.